Patients with cancer demonstrate an increased vulnerability for infection and severe disease
by SARS-CoV-2, the causative agent of COVID-19. Risk factors for severe COVID-19 include …

Simple Summary Coronavirus disease 2019 (COVID-19) is the greatest present-day public
and global health challenge, and patients with cancer are especially vulnerable …

Hematopoietic cell transplantation (HCT) and chimeric antigen receptor T cell therapy (CAR-
T) recipients who develop Coronavirus disease 2019 (COVID-19) can have decreased …

Background The role and the durability of the immunogenicity of the third dose of vaccine
against COVID-19 variants of concern in cancer patients have to be elucidated. Patients and …

ASCO Guidelines provide recommendations with comprehensive review and analyses of
the relevant literature for each recommendation, following the guideline development …

ABSTRACT COVID-19 vaccination is effective for cancer patients without safety concerns.
However, COVID-19 vaccination hesitancy is common among cancer patients. This study …

Studies assessing the dynamics and duration of antibody responses following SARS-CoV-2
infection or vaccination are an invaluable tool for vaccination schedule planning …

Simple Summary Patients with lymphoma are at greater risk of complications from COVID-19
infection. However, limited data exists on COVID-19-related outcomes in lymphoma patients …

Abstract Purpose The SARS-CoV-2 Omicron variant of concern (VOC) and subvariants like
BQ. 1.1 demonstrate immune evasive potential. Little is known about the efficacy of booster …

There are limited data available about the durability of the immune response after
administration of the widely used adenovirus-vectored ChAdOx1-nCoV-19 vaccine in cancer …